National Science Foundation Awards SegAna Phase 1 SBIR Grant

UCF Business Incubation Program client developing radiation technology to fight cancer tumors in partnership with UCLA
Orlando, Fla. (February 26, 2018) – An Orlando-based company has been recognized by the federal government as innovating in the field of cancer research.
The company has been granted a Small Business Innovation Research (SBIR) Phase 1 grant valued at $225,000 from the National Science Foundation (NSF).
“It’s a great honor to be one of the few selected to receive a Phase 1 SBIR Grant from the National Science Foundation,” says Rodney Bosley, CEO and director of SegAna. “As we move forward in advancing the commercialization of SegAna’s real-time cloud-based treatment guidance software for radiation cancer treatment, grants like these are vital.”
The company was founded to bring technology developed at the University of Central Florida and the University of California Los Angeles together into a commercially available simulated lung. The grant is a cooperative grant with UCLA’s Department of Radiation Oncology.
Once fully developed, the technology will allow radiation oncologists to plan and deliver patient-specific, advanced treatments quickly and modified to suit the current tumor location and motion. More importantly, it only delivers radiation to the tumor and avoids normal tissues.
Specifically, SegAna’s technology will be a software framework that provides treatment guidance for radiotherapy. The software provides near real-time computing performance facilitating clinical decision-making for adaptive radiotherapy.
“We’ve been able to show in our research how this technology will improve radiation treatment, the patient’s quality of life, and ultimately, reduce the number of times a patient is readmitted to the hospital,” Bosley adds.
The grant has allowed the company to hire three additional software engineers.
# # #
For more information media should contact –
Tres Riley, Chief Commercialization Officer, SegAna, 817-455-0575,
Carol Ann Dykes Logue, Site Manager, UCF Business Incubation Program, 407-635-9882,
Alan Byrd, Alan Byrd & Associates, 407-415-8470,
About SegAna: SegAna, LLC, is a medical technology company that will provide software for near-real time treatment guidance that facilitates clinical decision making for adaptive radiotherapy. Segana will also manufacture and sell deformable four-dimensional lung phantom simulators for enhancing lung cancer radiation treatment. Each phantom is manufactured with the patient’s specific lung details which trains the physician to develop precise treatment parameters. For more information, please visit
About the UCF Business Incubation Program: The University of Central Florida Business Incubation Program is a community resource that provides early-stage companies with the tools, training and infrastructure to become financially stable, high growth/impact enterprises. Since 1999, this award-winning program has helped more than 390 local startup companies reach their potential faster by providing vital business development resources.
With seven facilities throughout the region, the UCF Business Incubation Program is an economic development partnership between the University of Central Florida, the Corridor, Orange, Osceola, Seminole and Volusia counties, and the cities of Apopka, Kissimmee, Orlando and Winter Springs. For the 2014/15 and 2015/16 fiscal years, the activities of these participating firms have helped sustain more than 4,710 local jobs and have had a cumulative impact of more than $725 million on regional GDP and more than $1.3 billion on regional sales. During the same period, the program has returned $7.41 for every $1 invested in the program. For more information, visit


Facebook icon
Twitter icon
LinkedIn icon
Pinterest icon
e-mail icon